Search results for "ASTHMA"

showing 10 items of 860 documents

Fractional exhaled nitric oxide is associated with more severe asthma

2018

Fractional exhaled nitric oxide (FeNO) levels are used as a marker of airway inflammation. The aim of the present work was to evaluate a possible relationship between FeNO and parameters of asthma control and severity in different asthma phenotypes. FeNO was evaluated in 200 asthma patients (37% male, mean age ± SD 54±15 years, 19% controlled (GINA), 30% treated with oral corticosteroids (OCS), median FEV1 (interquartile range) 2,05 L (1,49-2,70), 74% pred. (56-90%)), together with other asthma characteristics (lung function, asthma control, allergies, serum IgE, serum ECP, and blood eosinophils). Patients with poorly controlled asthma had significantly higher FeNO values (ACQ-5≥1.5 vs. 70%…

medicine.medical_specialtyAllergybiologybusiness.industrySevere asthmaAirway inflammationrespiratory systemImmunoglobulin Emedicine.diseaseGastroenterologySerum igerespiratory tract diseases03 medical and health sciences0302 clinical medicine030228 respiratory systemInterquartile rangeInternal medicineExhaled nitric oxidemedicinebiology.protein030212 general & internal medicinebusinessAsthmaMonitoring Airway Disease
researchProduct

Patients with allergic and eosinophilic asthma in the German severe asthma registry

2015

Targeted treatment strategies for asthma require a precise diagnosis of phenotypes. 308 adult patients (age mean±SD: 50.3±13.5yrs) with severe asthma from the German Severe Asthma Registry (www.german-asthma-net.de) were evaluated based on history of allergy symptoms, results of skin prick tests, total/specific IgE, and blood cell differentials. 121 patients (39%) showed typical signs of allergic asthma including allergic symptoms and a positive skin prick test and/or specific IgE with no elevated blood eosinophils (median total IgE: 222 (range 4-4023) IU/ml, eosinophils: 128 (0-295)/µl, FeNO: 23 (7-300) ppb). 53 (43.8%) of these patients were treated with omalizumab. 50 patients (16%) had …

medicine.medical_specialtyAllergybiologybusiness.industrySevere asthmaOmalizumabDiseaserespiratory systemmedicine.diseaseImmunoglobulin EGastroenterologyrespiratory tract diseasesSerologyInternal medicineImmunologyEosinophilicmedicinebiology.proteinbusinessmedicine.drugAsthma5.3 Allergy and Immunology
researchProduct

Early exposure to paracetamol or to antibiotics and eczema at school age: Modification by asthma and rhinoconjunctivitis

2010

The association between early exposure to paracetamol or to antibiotics and eczema is conflicting. This study aims to know whether the early exposure to those drugs is associated with eczema at school age, and whether the strength of the association is modified by the presence of asthma or rhinoconjunctivitis. Children aged 6-7 (n = 13908) from the International Study of Asthma and Allergies in Childhood in Spain provided data about current asthma, rhinoconjunctivitis and eczema. Parent-reported information was also obtained on paracetamol and antibiotic consumption during the first year of life. Logistic regression analysis with eczema as outcome and including exposure to paracetamol or to…

medicine.medical_specialtyAllergymedicine.drug_classbusiness.industryImmunologyAntibioticsRespiratory diseasePrevalencemedicine.diseaseLogistic regressionAcetaminophenPharmacotherapyimmune system diseasesInternal medicinePediatrics Perinatology and Child HealthImmunologymedicineImmunology and AllergybusinessAsthmamedicine.drugPediatric Allergy and Immunology
researchProduct

Patient Baseline Characteristics Predict An Increased Risk Of Future Asthma Exacerbations

2010

medicine.medical_specialtyAsthma exacerbationsIncreased riskbusiness.industryBaseline characteristicsEmergency medicinePhysical therapyMedicinebusinessC93. MOLECULAR AND CLINICAL PHENOTYPING OF ASTHMA
researchProduct

Clinically meaningful FEV1 response with reslizumab achieved early and sustained over 52 weeks

2017

Background: Reslizumab (RES) is a humanized anti-interleukin-5 monoclonal antibody that significantly reduces the risk of asthma exacerbations and improves asthma control, lung function, and quality of life in patients with uncontrolled eosinophilic asthma. The mean difference in FEV 1 in RES treated patients vs placebo (PBO) at 16 and 52 weeks has been shown to be statistically and clinically significant (Castro et al., Lancet Respir Med. 2015; 3:355–366), but individual responders have not been assessed. Aims/Objectives: To assess the proportion of RES-treated patients who achieved a ≥0.1L increase in FEV 1 from baseline and the duration of treatment before response occurs. Methods: This …

medicine.medical_specialtyAsthma exacerbationsbusiness.industryEosinophilic asthmaPlaceboMean differenceReslizumabQuality of lifeInternal medicineAsthma controlmedicinebusinessLung functionmedicine.drugAirway Pharmacology and Treatment
researchProduct

Budesonide/Formoterol Maintenance And Reliever Therapy In Patients With Difficult-To-Control Asthma

2011

medicine.medical_specialtyBudesonide/formoterolbusiness.industryInternal medicineMedicineIn patientbusinessmedicine.diseaseAsthmamedicine.drugA31. OPTIMIZING THERAPEUTIC STRATEGIES IN AIRWAYS DISEASE
researchProduct

<p>Day and Night Control of COPD and Role of Pharmacotherapy: A Review</p>

2020

The topic of 24-hour management of COPD is related to day-to-night symptoms management, specific follow-up and patients' adherence to therapy. COPD symptoms strongly vary during day and night, being worse in the night and early morning. This variability is not always adequately considered in the trials. Night-time symptoms are predictive of higher mortality and more frequent exacerbations; therefore, they should be a target of therapy. During night-time, in COPD patients the supine position is responsible for a different thoracic physiology; moreover, during some sleep phases the vagal stimulation determines increased bronchial secretions, increased blood flow in the bronchial circulation (…

medicine.medical_specialtyCOPDEveningbusiness.industryGeneral MedicineDiseasemedicine.diseaseSleep medicinerespiratory tract diseases03 medical and health sciences0302 clinical medicinePharmacotherapy030228 respiratory systemBronchiolitisInternal medicinemedicine030212 general & internal medicinebusinessDynamic hyperinflationAsthmaInternational Journal of Chronic Obstructive Pulmonary Disease
researchProduct

Functional imaging of airway distensibility

2014

The physiological function of the respiratory system is essential in distending airway smooth muscle and maintaining airway patency. Deep inspirations can reverse contracted airways and protect airways from subsequent bronchospastic stimuli. Obstructive lung diseases may lead to impairment of the beneficial effects of lung inflation through either change in the airway wall or lung parenchyma. Conventional pulmonary function measurements are unable to assess airway stiffness, based on changes in airway size with lung inflation (distensibility). However, high-resolution computed tomography (HRCT) is unique in that it can be used to measure airway distensibility in animals and in humans. Funct…

medicine.medical_specialtyCOPDLungbusiness.industryrespiratory systemSettore MED/10 - Malattie Dell'Apparato Respiratoriomedicine.diseaserespiratory tract diseasesPulmonary function testingFunctional imagingmedicine.anatomical_structuredeep inspirationInternal medicineParenchymamedicineCardiologyRespiratory systemAirwaybusinessAsthma
researchProduct

2017

T1 maps have been shown to yield useful diagnostic information on lung function in patients with chronic obstructive pulmonary disease (COPD) and asthma, both for native T1 and ΔT1, the relative reduction while breathing pure oxygen. As parameter quantification is particularly interesting for longitudinal studies, the purpose of this work was both to examine the reproducibility of lung T1 mapping and to compare T1 found in COPD and asthma patients using IRSnapShotFLASH embedded in a full MRI protocol. 12 asthma and 12 COPD patients (site 1) and further 15 COPD patients (site 2) were examined on two consecutive days. In each patient, T1 maps were acquired in 8 single breath-hold slices, brea…

medicine.medical_specialtyCOPDMultidisciplinaryLungbusiness.industrymedicine.diseaserespiratory tract diseases030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicine.anatomical_structure030228 respiratory systemInternal medicineRespirationBreathingRoom air distributionCardiologyMedicinebusinessProspective cohort studyPerfusionAsthmaPLOS ONE
researchProduct

Relationship between sleep disturbances and peripheral airway abnormalities in COPD patients

2017

Background: Individuals with COPD experience sleep disturbances due to the impact of symptoms on quality of sleep. Aim: To test the hypothesis that, in COPD, sleep disturbances are linked to peripheral airway abnormalities. Methods: An investigational study is being performed at the University of Palermo, Italy. The impact of breathing problems on quality of sleep during the previous week is measured with the COPD and Asthma Sleep Impact Scale (CASIS) questionnaire. Airway resistances by impulse oscillometry (IOS) assesses peripheral airway abnormalities. Lung function evaluation includes static and dynamic lung volume measurements. To rule out the risk of having obstructive sleep apnea, th…

medicine.medical_specialtyCOPDbusiness.industryAirway obstructionmedicine.diseaseAir trappingInterim analysisrespiratory tract diseasesObstructive sleep apneaImpulse OscillometryInternal medicinemedicineCardiologymedicine.symptomAirwaybusinessAsthmaClinical Problems Asthma
researchProduct